Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

California Resources (CRC) Liabilities and Shareholders Equity (2016 - 2025)

California Resources' Liabilities and Shareholders Equity history spans 12 years, with the latest figure at $7.4 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 3.76% year-over-year to $7.4 billion; the TTM value through Dec 2025 reached $14.2 billion, up 98.37%, while the annual FY2025 figure was $7.4 billion, 3.76% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $7.4 billion at California Resources, up from $6.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $7.4 billion in Q4 2025 and bottomed at $3.2 billion in Q1 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $4.0 billion (2023), against an average of $4.6 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity decreased 0.79% in 2023 before it soared 78.46% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.8 billion in 2021, then rose by 3.15% to $4.0 billion in 2022, then grew by 0.78% to $4.0 billion in 2023, then surged by 78.46% to $7.1 billion in 2024, then grew by 3.76% to $7.4 billion in 2025.
  • Per Business Quant, the three most recent readings for CRC's Liabilities and Shareholders Equity are $7.4 billion (Q4 2025), $6.8 billion (Q3 2025), and $7.1 billion (Q4 2024).